Bio-Rad Laboratories, Inc. (BIO) vs Shoulder Innovations, Inc. (SI)
BIO leads on 6 of 7 compared metrics.
A side-by-side comparison of Bio-Rad Laboratories, Inc. and Shoulder Innovations, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 21, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
BIO
Bio-Rad Laboratories, Inc.
$282.44Healthcare
SI
Shoulder Innovations, Inc.
$18.55Healthcare
Total return — BIO vs SI
growth of $100 · last 1yBIO +12.9%SI +23.3%SI compounded faster
BIO SI
BIO vs SI: by the numbers
- •BIO is the larger company ($7.64B vs $385M market cap).
- •BIO is profitable (6.52% net margin) while SI runs a net loss (-81.78%).
Metrics side by side
Valuation
| Metric | BIO | SI |
|---|---|---|
| P/E ratio | 46.53 | — |
| Forward P/E | 28.34 | — |
| P/S ratio | 2.94● | 7.11 |
| P/B ratio | 1.11● | 2.88 |
| EV / EBITDA | 18.06 | — |
| FCF yield | 4.69% | — |
Profitability
| Metric | BIO | SI |
|---|---|---|
| Gross margin | 51.87% | 75.48%● |
| Operating margin | 9.25%● | -57.48% |
| Net margin | 6.52%● | -81.78% |
| ROE | 2.46%● | -33.14% |
| ROIC | 2.04%● | -14.80% |
Growth (annualized)
| Metric | BIO | SI |
|---|---|---|
| Revenue CAGR (5Y) | -0.84% | — |
| EPS CAGR (5Y) | -26.27% | — |
| FCF CAGR (5Y) | -7.57% | — |
| Total return CAGR (5Y) | -14.63% | — |
Frequently asked
- Is BIO or SI more profitable?
- BIO runs the higher net margin — BIO at 6.52% versus SI at -81.78%.
Go deeper
Dig into the metrics
Bio-Rad Laboratories P/E ratioShoulder Innovations P/E ratioBio-Rad Laboratories dividend yieldShoulder Innovations dividend yieldBio-Rad Laboratories ROEShoulder Innovations ROEBio-Rad Laboratories operating marginShoulder Innovations operating marginBio-Rad Laboratories revenue growthShoulder Innovations revenue growthBio-Rad Laboratories free cash flowShoulder Innovations free cash flow
Bio-Rad Laboratories & Shoulder Innovations appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 21, 2026.